A significant discovery in cancer research is arising with the use of nanobodies to reactivate dysfunctional p53. This essential malignant inhibitor protein is frequently lost in several forms of tumors, leading https://socialicus.com/story7469350/mini-antibodies-restore-p53-the-potential-approach-for-malignant-therapy